This study investigates the clinical performance of a diagnostic test in identifying Streptococcus agalactiae, also known as Group B Streptococcus (GBS), from samples collected from women. GBS is a type of bacteria that can be found in the body and may cause infections, particularly in newborns. The study uses enriched LIM broth cultures to enhance the detection of GBS from vaginal and/or rectal swabs.

Participants in the study will undergo procedures to collect vaginal and/or rectal swabs. These samples will then be used to test the effectiveness of the diagnostic assay in identifying the presence of GBS. The study aims to validate the assay's accuracy in a clinical setting.

• Who can participate: Women aged 18 years and older who are capable of providing informed consent and are willing to undergo vaginal and/or rectal swab collection are eligible to participate. Key eligibility factors include the absence of antibiotic use in the last two weeks and no known allergies to swab materials.
• Study details: Participants will provide vaginal and/or rectal swabs for testing. The samples will be used to evaluate the diagnostic assay's ability to detect GBS.